Rheumatoid Arthritis
2,489
138
210
1,610
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
662 trials with published results (27%)
Research Maturity
1610 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.3%
206 terminated out of 2489 trials
88.7%
+2.2% vs benchmark
24%
587 trials in Phase 3/4
41%
662 of 1610 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1610 completed trials
Clinical Trials (2489)
Interest of a Nursing Consultation in the Empowerment of the Patient With Rheumatoid Arthritis in the Management of His Subcutaneous Biotherapy
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
An Open-label Study of GC012F in Rheumatoid Arthritis.
Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
TESS V3 Modular Total Shoulder System PMCF
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Study of GS-0151 in Participants With Rheumatoid Arthritis
Comprehensive Segmental Revision System
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
Desloratadine as Adjunct Therapy for Rheumatoid Arthritis
Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))